Edition:
India

Genetic Technologies Ltd (GENE.OQ)

GENE.OQ on NASDAQ Stock Exchange Capital Market

1.08USD
1:30am IST
Change (% chg)

$0.01 (+0.93%)
Prev Close
$1.07
Open
$1.07
Day's High
$1.08
Day's Low
$1.07
Volume
2,529
Avg. Vol
17,549
52-wk High
$2.05
52-wk Low
$0.70

Chart for

About

Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment... (more)
No analyst recommendations are available for .

Overall

Beta: 2.64
Market Cap(Mil.): $15.14
Shares Outstanding(Mil.): 16.24
Dividend: --
Yield (%): --

Financials

BRIEF-Genetic Technologies Enters Into A Non-Binding Terms Sheet With Omix Ventures Private ​

* ENTERED INTO A NON-BINDING TERMS SHEET WITH OMIX VENTURES PRIVATE ​

06 Mar 2018

BRIEF-Genetic Technologies Says H1 Comprehensive Loss Attributable $3.3 Mln

* H1 REVENUE FROM CONTINUING OPERATIONS - GENETIC TESTING SERVICES $97.8 MILLION VERSUS $369.1 MILLION

27 Feb 2018

BRIEF-Genetic Technologies ‍Enters Terms Sheet With Blockchain Global​

* ‍ENTERED INTO NON-BINDING TERMS SHEET WITH BLOCKCHAIN GLOBAL​

15 Feb 2018

BRIEF-Genetic Technologies Says Eutillio​ ‍Buccilli To Step Down As CEO

* EUTILLIO​ ‍BUCCILLI WILL STEP DOWN AS CHIEF EXECUTIVE OFFICER WITH IMMEDIATE EFFECT

06 Feb 2018

BRIEF-Genetic Technologies Appointed Paul A. Kasian As Chairman

* MALCOLM. R BRANDON RESIGNS AS CHAIRMAN Source text for Eikon: Further company coverage:

05 Feb 2018

BRIEF-Genetic Technologies Seeks Trading Halt

* SEEKS TRADING HALT ‍PENDING AN ANNOUNCEMENT ON OUTCOME OF RESULTS OF GENERAL MEETING OF SHAREHOLDERS SCHEDULED​ Source text for Eikon: Further company coverage:

30 Jan 2018

Competitors

Earnings vs. Estimates